Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 28:80:11462.
doi: 10.3389/bjbs.2023.11462. eCollection 2023.

Changing Molecular Profiles of Human Cryptosporidiosis Cases in Scotland as a Result of the Coronavirus Disease, COVID-19 Pandemic

Ross Bacchetti  1 , Lisa Connelly  1 , Lynda Browning  2 , Claire L Alexander  1
Affiliations

Changing Molecular Profiles of Human Cryptosporidiosis Cases in Scotland as a Result of the Coronavirus Disease, COVID-19 Pandemic

Ross Bacchetti et al. Br J Biomed Sci. .

Abstract

Cryptosporidium, the most frequently reported parasite in Scotland, causes gastrointestinal illness resulting in diarrhoea, nausea and cramps. Two species are responsible for most cases: Cryptosporidium hominis (C. hominis) and Cryptosporidium parvum (C. parvum). Transmission occurs faecal-orally, through ingestion of contaminated food and water, or direct contact with faeces. In 2020, the COVID-19 pandemic led to global restrictions, including national lockdowns to limit viral transmission. Such interventions led to decreased social mixing, and reduced/no local and international travel, which are factors associated with transmission of multiple communicable diseases, including cryptosporidiosis. This report assessed the impact of the pandemic on Scottish cryptosporidiosis cases, and identified changes in circulating molecular variants of Cryptosporidium species. Molecular data generated using real time PCR and GP60 nested-PCR assays on laboratory-confirmed cryptosporidiosis cases reported during 2018-22 were analysed. The Scottish Microbiology Reference Laboratories (SMiRL), Glasgow, received 774 Cryptosporidium-positive faeces during 2018-22, of which 486 samples were successfully subtyped. During this time period, C. hominis (n = 155; 21%) and C. parvum (n = 572; 77%) were the most commonly detected species. The total number of cases during 2020, which was greatly affected by the pandemic, was markedly lower in comparison to case numbers in the 2 years before and after 2020. The most predominant C. hominis family detected prior to 2020 was the Ib family which shifted to the Ie family during 2022. The most common C. parvum variant during 2018-22 was the IIa family, however a rise in the IId family was observed (n = 6 in 2018 to n = 25 in 2022). The dominant C. hominis subtype IbA10G2, which accounted for 71% of C. hominis subtypes in 2018-19 was superseded by three rare subtypes: IeA11G3T3 (n = 15), IdA16 (n = 8) and IbA9G3 (n = 3) by 2022. Frequently reported C. parvum subtypes in 2018-19 were IIaA15G2R1 and IIaA17G1R1, accounting for 59% of total C. parvum subtypes. By 2022, IIaA15G2R1 remained the most common (n = 28), however three unusual subtypes in Scotland emerged: IIdA24G1 (n = 7), IIaA16G3R1 (n = 7) and IIaA15G1R2 (n = 7). Continuous monitoring of Cryptosporidium variants following the pandemic will be essential to explore further changes and emergence of strains with altered virulence.

Keywords: COVID-19 pandemic; Cryptosporidium; Scotland; human cryptosporidiosis; molecular variants.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Laboratory-confirmed cases of Cryptosporidium hominis (A) and Cryptosporidium parvum (B) in Scotland from 2018–22.
See this image and copyright information in PMC

References

    1. Deshpande AP, Jones BL, Connelly L, Pollock KG, Brownlie S, Alexander CL. Molecular Characterization of Cryptosporidium Parvum Isolates From Human Cryptosporidiosis Cases in Scotland. Parasitology (2015) 142(2):318–25. 10.1017/S0031182014001346 - DOI - PubMed
    1. Bouzid M, Hunter PR, Chalmers RM, Tyler KM. Cryptosporidium Pathogenicity and Virulence. Clin Microbiol Rev (2013) 26(1):115–34. 10.1128/CMR.00076-12 - DOI - PMC - PubMed
    1. Putignani L, Menichella D. Global Distribution, Public Health and Clinical Impact of the Protozoan Pathogen Cryptosporidium . Interdiscip Perspect Infect Dis (2010) 2010:753512. 10.1155/2010/753512 - DOI - PMC - PubMed
    1. Hønsvall BK, Robertson LJ. Real-Time Nucleic Acid Sequence-Based Amplification (NASBA) Assay Targeting MIC1 for Detection of Cryptosporidium Parvum and Cryptosporidium Hominis Oocysts. Exp Parasitol (2017) 172:61–7. 10.1016/j.exppara.2016.12.009 - DOI - PubMed
    1. Robinson G, Pérez-Cordón G, Hamilton C, Katzer F, Connelly L, Alexander CL, et al. Validation of a Multilocus Genotyping Scheme for Subtyping Cryptosporidium Parvum for Epidemiological Purposes. Food Waterborne Parasitol (2022) 27:e00151. 10.1016/j.fawpar.2022.e00151 - DOI - PMC - PubMed